The Human Behavioral Pharmacology Subprogram

Diverse New Treatments for Drug Abuse.

The Human Behavioral Pharmacology Laboratory (HBPL), established in 1986, is a research unit of the Department of Psychiatry that studies environmental and pharmacological factors that influence drug abuse and diverse new treatments for drug abuse.

woman working in a lab Our research spans alcohol, amphetamines, benzodiazepines, cannabinoids, caffeine, cocaine, nicotine, and opioids. Research includes both clinical research on behavioral and pharmacological treatments for cocaine, nicotine, opiate, alcohol and marijuana dependence and human laboratory research on behavioral effects of abused drugs.

Major sources of research funding are the National Institute on Drug Abuse (NIDA), and parmaceutical companies. All of these sources can be used to support medical psychology graduate training.

The HBPL also provides training that is funded via a NIH/NIDA Institutional Research Training Award. This subprogram supports three predoctoral fellowships, and three postdoctoral fellowships.

Predoctoral Fellows typically are full time graduate students in the UVM Department of Psychology. The HBPL is fully integrated with the Department of Psychology; the four primary investigators hold joint appointments in the Department of Psychiatry and Psychology. The training period will be 4 to 5 years resulting in a Ph.D. in general/experimental or clinical psychology.

Postdoctoral Fellows conduct independent research at one or more of three facilities that make up the HBPL. The training period is 1 to 3 years.